RPCEC00000284
Recruiting
未知
Evaluation of the behavior of platelets count, EGF serum concentrations and the levels of lymphocytes subpopulations expression associated with the patient's immune status as possible biomarkers of effectiveness of CIMAvax-EGF vaccine.
Center of Molecular Immunology (CIM)0 sitesAugust 3, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Advanced non small cell lung cancer
- Sponsor
- Center of Molecular Immunology (CIM)
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients of any sex and age similar or more than 18 years.
- •2\. Patients that complete the diagnostic criteria.
- •3\. Patients included in another clinical trial in which the therapeutic vaccine CIMAvax\-EGF® is administered, or that they don't receive products in investigation and be managed follow up the Cuban Guide of treatment of patient with lung cancer 2016 version.
- •4\. Patient that have signed the informed consent for the investigation.
- •5\. Patient with performan status (ECOG) state from 0 at 3
Exclusion Criteria
- •1\. Patient in fertile age that are not using an appropriate (intra\-uterine devices, hormonal contraceptives, barrier methods or bond of trumpets) method of contraception. For the males (vasectomy, use of preservatives) while the treatment lasts
- •2\. Pregnant, lactating or puerperal patients.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
To evaluate the effect of platelet-rich plasma in bone healing of acute diaphyseal fractures of the tibiapatients who ere diagnosed as acute closed fracture of tibial shaft and underwent surgery with intramedullary nailplatelet-rich plasma, prp, tibia fracture, bone healing, cortex-to-callus ratio, biological augmentation, regenerative medicineTCTR20210220003H.R.H. Maha Chakri Sirindhorn Medical Center (MSMC)32
Withdrawn
Not Applicable
An evaluation of platelet activation and function in different haematological disorders pre and post treatment using flow cytometry and extracellular regulatory kinase pathwayPlatelet activation and function pre and post treatment in haematological disordersBlood - Haematological diseasesACTRN12610000313033aunceston General Hospital80
Recruiting
Not Applicable
Platelet function assessed via Multiplate® and thrombomiR in patients with traumatic brain injury receiving aspirin: a prospective, observational pilot study.S06Intracranial injuryDRKS00006036Medizinische Universität Wien160
Completed
Not Applicable
Evaluation and validation of platelet function using multiplate before cardiac surgery.Trombocythopathy10035534reduced platelet functionNL-OMON42206Sint Antonius Ziekenhuis40
Active, not recruiting
Not Applicable
Evaluation of platelet functional response in patients with acute coronary syndromes without ST-segment elevation (NSTEACS)treated with clopidogrel.EUCTR2012-003125-24-ITA.O. UNIVERSITARIA INTEGRATA DI VERONA